DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Stopeck A, Brufsky A, Kennedy L. et al
Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States.
J Med Econ 2020;
23 (01) 37-47
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.